404 related articles for article (PubMed ID: 7634816)
21. Impact on Efficacy and Safety of Hydrocortisone in Sepsis and Septic Shock - A Systematic Literature Review and Meta-analysis.
Aletreby WT; Alharthy AM; Madi AF; Soliman IR; Hamido HM; Ramadan OE; Alzayer W; Huwait BM; Alodat MA; Mumtaz SA; Mahmood NN; Al Kurdi MH; Farrag HA; Karakitsos D
Arch Iran Med; 2019 Jul; 22(7):394-402. PubMed ID: 31679383
[TBL] [Abstract][Full Text] [Related]
22. Corticosteroids in sepsis: an updated systematic review and meta-analysis (protocol).
Rochwerg B; Oczkowski S; Siemieniuk RA; Menon K; Szczeklik W; English S; Agoritsas T; Belley-Cote E; D'Aragon F; Alhazzani W; Duan E; Gossack-Keenan K; Sevransky J; Vandvik P; Venkatesh B; Guyatt G; Annane D
BMJ Open; 2017 Jun; 7(6):e016847. PubMed ID: 28667229
[TBL] [Abstract][Full Text] [Related]
23. Human recombinant activated protein C for severe sepsis.
Martí-Carvajal AJ; Solà I; Lathyris D; Cardona AF
Cochrane Database Syst Rev; 2012 Mar; (3):CD004388. PubMed ID: 22419295
[TBL] [Abstract][Full Text] [Related]
24. Intravenous immunoglobulin for treating sepsis and septic shock.
Alejandria MM; Lansang MA; Dans LF; Mantaring JB
Cochrane Database Syst Rev; 2001; (2):CD001090. PubMed ID: 11405973
[TBL] [Abstract][Full Text] [Related]
25. The use of steroids in the treatment of severe sepsis and septic shock.
Batzofin BM; Sprung CL; Weiss YG
Best Pract Res Clin Endocrinol Metab; 2011 Oct; 25(5):735-43. PubMed ID: 21925074
[TBL] [Abstract][Full Text] [Related]
26. Recent Updates in the Pharmacological Management of Sepsis and Septic Shock: A Systematic Review Focused on Fluid Resuscitation, Vasopressors, and Corticosteroids.
Allen JM; Feild C; Shoulders BR; Voils SA
Ann Pharmacother; 2019 Apr; 53(4):385-395. PubMed ID: 30404539
[TBL] [Abstract][Full Text] [Related]
27. Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials.
Vasu TS; Cavallazzi R; Hirani A; Kaplan G; Leiby B; Marik PE
J Intensive Care Med; 2012; 27(3):172-8. PubMed ID: 21436167
[TBL] [Abstract][Full Text] [Related]
28. Polymyxin B-immobilised haemoperfusion and mortality in critically ill patients with sepsis/septic shock: a protocol for a systematic review and meta-analysis.
Fujii T; Ganeko R; Kataoka Y; Featherstone R; Bagshaw SM; Furukawa TA
BMJ Open; 2016 Nov; 6(11):e012908. PubMed ID: 27872122
[TBL] [Abstract][Full Text] [Related]
29. The controversial role of corticosteroids in septic shock.
Pourmand A; Whiteside T; Yamane D; Rashed A; Mazer-Amirshahi M
Am J Emerg Med; 2019 Jul; 37(7):1353-1361. PubMed ID: 31056383
[TBL] [Abstract][Full Text] [Related]
30. The Effectiveness and Safety of Corticosteroids Therapy in Adult Critical Ill Patients With Septic Shock: A Meta-Analysis of Randomized Controlled Trials.
Wen Y; Zhu Y; Jiang Q; Guo N; Cai Y; Shen X
Shock; 2019 Aug; 52(2):198-207. PubMed ID: 29889815
[TBL] [Abstract][Full Text] [Related]
31. Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock.
Kreymann KG; de Heer G; Nierhaus A; Kluge S
Crit Care Med; 2007 Dec; 35(12):2677-85. PubMed ID: 18074464
[TBL] [Abstract][Full Text] [Related]
32. Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis.
Fujii T; Ganeko R; Kataoka Y; Furukawa TA; Featherstone R; Doi K; Vincent JL; Pasero D; Robert R; Ronco C; Bagshaw SM
Intensive Care Med; 2018 Feb; 44(2):167-178. PubMed ID: 29204670
[TBL] [Abstract][Full Text] [Related]
33. Blood Purification and Mortality in Sepsis and Septic Shock: A Systematic Review and Meta-analysis of Randomized Trials.
Putzu A; Schorer R; Lopez-Delgado JC; Cassina T; Landoni G
Anesthesiology; 2019 Sep; 131(3):580-593. PubMed ID: 31246600
[TBL] [Abstract][Full Text] [Related]
34. De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock.
Gomes Silva BN; Andriolo RB; Atallah AN; Salomão R
Cochrane Database Syst Rev; 2010 Dec; (12):CD007934. PubMed ID: 21154391
[TBL] [Abstract][Full Text] [Related]
35. The influence of esmolol on septic shock and sepsis: A meta-analysis of randomized controlled studies.
Liu P; Wu Q; Tang Y; Zhou Z; Feng M
Am J Emerg Med; 2018 Mar; 36(3):470-474. PubMed ID: 29269160
[TBL] [Abstract][Full Text] [Related]
36. Early goal-directed therapy in the management of severe sepsis or septic shock in adults: a meta-analysis of randomized controlled trials.
Zhang L; Zhu G; Han L; Fu P
BMC Med; 2015 Apr; 13():71. PubMed ID: 25885654
[TBL] [Abstract][Full Text] [Related]
37. The International Sepsis Forum's controversies in sepsis: corticosteroids should be used to treat septic shock.
Goodman S; Sprung CL;
Crit Care; 2002 Oct; 6(5):381-3. PubMed ID: 12398770
[TBL] [Abstract][Full Text] [Related]
38. Corticosteroids in sepsis and septic shock: has the jury reached a verdict?
Putterman C
Isr J Med Sci; 1989 Jun; 25(6):332-8. PubMed ID: 2661496
[TBL] [Abstract][Full Text] [Related]
39. High-volume haemofiltration for sepsis.
Borthwick EM; Hill CJ; Rabindranath KS; Maxwell AP; McAuley DF; Blackwood B
Cochrane Database Syst Rev; 2013 Jan; (1):CD008075. PubMed ID: 23440825
[TBL] [Abstract][Full Text] [Related]
40. Early outcome of early-goal directed therapy for patients with sepsis or septic shock: a systematic review and meta-analysis of randomized controlled trials.
Chen X; Zhu W; Tan J; Nie H; Liu L; Yan D; Zhou X; Sun X
Oncotarget; 2017 Apr; 8(16):27510-27519. PubMed ID: 28460438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
